SBW Life Science Provides Collateral to Third Parties Worth 7.8 Billion KRW
SBW Life Science announced on the 19th that it has decided to provide collateral worth 7.8 billion KRW to its subsidiary Enrich Holdings. The collateral amount represents 24.14% of its equity capital. The collateralized asset is the first-priority preferential beneficiary right under a real estate trust contract, with the period from November 5, 2022, to November 4, 2023.
Hot Picks Today
!["What If the KOSPI Plummets?... Record Funds Flow into 'Target Maturity Funds' [Investment Trends]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026043008433546440_1777506215.jpg)
"What If the KOSPI Plummets?... Record Funds Fl...
- "If It's Uncomfortable, They Cut Ties": Three Out of Five U.S. Gen Z Have Broken...
- "Parents Deposited 10 Million Won for Me"... Securities Accounts Surge 272% Amid...
- Just Eating Eggs Twice a Week... Dementia Risk Drops Significantly
- Did Her Wealthy Husband Quash the Investigation? Yang Jungwon Appears Before Pol...
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
